Related Experiment Video

Updated: Aug 15, 2026

Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface
07:00

Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface

Published on: August 11, 2017

The difficulties industry is facing with investigators

George R P Blackledge1

  • 1AstraZeneca Pharmaceuticals, Medical Oncology, Alderley House, Alderley Park, Macclesfield, Cheshire SK10 4TF, UK. george.blackledge@astrazeneca.com

European Journal of Cancer (Oxford, England : 1990)
|October 11, 2005
PubMed

Insights

The development of new cancer treatments has increased, leading to more collaborations between pharmaceutical companies and medical researchers. This paper addresses challenges and solutions arising from these partnerships.

Area of Science:

  • Oncology
  • Pharmaceutical Science
  • Clinical Research

Background:

  • The past decade has seen a significant rise in novel anti-cancer agent development.
  • This surge has intensified collaborations between the pharmaceutical industry and academic/clinical researchers.

Purpose of the Study:

  • To identify key issues arising from industry-academia interactions in cancer drug development.
  • To propose actionable solutions for optimizing these collaborations.

Main Methods:

  • Qualitative analysis of industry-academia interactions.
  • Identification of common challenges faced by both sectors.
  • Development of proposed solutions based on identified issues.

Main Results:

  • Several challenges were identified in the collaboration process.
  • Specific areas of friction include intellectual property, data sharing, and regulatory hurdles.
  • Proposed solutions aim to streamline processes and improve communication.

Conclusions:

  • Addressing identified issues is crucial for efficient cancer drug development.
  • Enhanced collaboration frameworks can accelerate the delivery of new cancer therapies to patients.
  • Proactive problem-solving will benefit both pharmaceutical developers and clinical investigators.

Related Concept Videos

Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
Inductively Coupled Plasma-Mass Spectrometry (ICP-MS): Interferences01:20

Inductively Coupled Plasma-Mass Spectrometry (ICP-MS): Interferences

Inductively coupled plasma–mass spectrometry (ICP–MS) is a highly selective and sensitive technique for accurate elemental analysis. Though the analysis of ICP–MS mass spectra is comparatively straightforward, it is affected by spectroscopic and non-spectroscopic interferences. Spectroscopic interferences arise when the plasma contains ionic species with an m/z value the same as the analyte ion. Spectroscopic interference can be categorized as isobaric, polyatomic ions, and refractory oxide ion...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Ethics in Research01:56

Ethics in Research

Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
Atomic Absorption Spectroscopy: Interference01:25

Atomic Absorption Spectroscopy: Interference

Interference leads to systematic error in atomic absorption (AA) measurements by enhancing or diminishing the analytical signal or the background. These interferences can be grouped into three main categories: spectral interference, chemical interference, and physical interference.
Spectral interference occurs when signals from other elements or molecules overlap with the analyte signal, falsely elevating or masking the analyte's absorbance. This interference can be corrected using Zeeman,...